Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of genetically engineered strain VNP20009-M in preventing and treating cancer metastasis

Use of genetically engineered strain VNP20009-M in preventing and treating cancer metastasis

US Patent 12478664 · Granted Nov 25, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Potassium salt crystal form B of phosphodiesterase type 5 inhibitor, and prepara2025
Potassium salt crystal form B of phosphodiesterase type 5 inhibitor, and prepara2025
Potassium salt crystal form B of phosphodiesterase type 5 inhibitor, and prepara2025
Applications of genetically engineered bacteria VNP20009-M in preparation of dru2023
Applications of genetically engineered bacteria VNP20009-M in preparation of dru2023
Application of genetically engineered bacteria VNP20009-M in preparing drug for 2022
Application of genetically engineered bacteria VNP20009-M in preparing drug for 2022
Use of genetically engineered bacterium of attenuated Salmonella typhimurium in 2022
Use of genetically engineered bacterium of attenuated Salmonella typhimurium in 2022
Application of phosphodiesterase 4 inhibitor ZL-n-91 in preparation of medicatio2021
Use of GABAA receptor reinforcing agent in preparation of sedative and anestheti2020
Method for synthesizing tetrahydroisoquinoline thiazolidine2019